BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y, Sun X, Shen B. Molecular Imaging of IGF-1R in Cancer. Mol Imaging 2017;16:1536012117736648. [PMID: 29169312 DOI: 10.1177/1536012117736648] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Kang J, Guo Z, Zhang H, Guo R, Zhu X, Guo X. Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer. IJMS 2022;23:10382. [DOI: 10.3390/ijms231810382] [Reference Citation Analysis]
2 Zhao D, Hu G, Chen R, Xiao G, Teng S. Molecular cloning, characterization, and tissue distribution of c-Myc from blood clam Tegillarca granosa and its role in cadmium-induced stress response. Gene 2022;834:146611. [PMID: 35618219 DOI: 10.1016/j.gene.2022.146611] [Reference Citation Analysis]
3 Liu Y, Yu S, Xu T, Bodenko V, Orlova A, Oroujeni M, Rinne SS, Tolmachev V, Vorobyeva A, Gräslund T. Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT. Pharmaceutics 2022;14:1475. [PMID: 35890370 DOI: 10.3390/pharmaceutics14071475] [Reference Citation Analysis]
4 Wang K, Liu J, Li Y, Li J, Zhang R. Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022;1877:188723. [DOI: 10.1016/j.bbcan.2022.188723] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Chegu A, Panikar SS, Pereira PM. Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity. Nuclear Medicine and Biology 2022. [DOI: 10.1016/j.nucmedbio.2022.03.004] [Reference Citation Analysis]
6 Yuan B, Zhao X, Wang X, Liu E, Liu C, Zong Y, Jiang Y, Hou M, Chen Y, Chen L, Zhang Y, Wang H, Fu J. Patient‐derived organoids for personalized gallbladder cancer modelling and drug screening. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Bolcaen J, Nair S, Driver CHS, Boshomane TMG, Ebenhan T, Vandevoorde C. Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals (Basel) 2021;14:626. [PMID: 34209513 DOI: 10.3390/ph14070626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Mutlu Güner S, Dölek Güler S, Kayhan KB, Namdar Pekiner F, Başaran B, Alatli FC. EXPRESSIONS OF IGF-1R, EZH2, LAMININ-5 IN LEUKOPLAKIA AND ORAL SQUAMOUS CELL CARCINOMA. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi 2021. [DOI: 10.17567/ataunidfd.890469] [Reference Citation Analysis]
9 Tateo V, Manuzzi L, Parisi C, De Giglio A, Campana D, Pantaleo MA, Lamberti G. An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances. Pharmaceuticals (Basel) 2021;14:316. [PMID: 33915954 DOI: 10.3390/ph14040316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Zhao B, Zhang Z, Chen X, Shen Y, Qin Y, Yang X, Xing Z, Zhang S, Long X, Zhang Y, An S, Wu H, Qi Y. The important roles of protein SUMOylation in the occurrence and development of leukemia and clinical implications. J Cell Physiol 2021;236:3466-80. [PMID: 33151565 DOI: 10.1002/jcp.30143] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
11 Ahmad SS, Ahmad K, Lee EJ, Lee YH, Choi I. Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases. Cells 2020;9:E1773. [PMID: 32722232 DOI: 10.3390/cells9081773] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 19.5] [Reference Citation Analysis]
12 Ben Elhadj M, Goucha A, Fourati A, Adouni O, Dhambri S, Hsairi M, El May MV, Mokni Baizig N. The Prognostic Significance of IGF-1R and the Predictive Risk Value of Circulating IGF-1 in Tunisian Patients with Laryngeal Carcinoma. Cancer Invest 2020;38:289-99. [PMID: 32308049 DOI: 10.1080/07357907.2020.1758711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Chen YM, Qi S, Perrino S, Hashimoto M, Brodt P. Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug. Cells 2020;9:E1098. [PMID: 32365498 DOI: 10.3390/cells9051098] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
14 Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY, Cai W. ImmunoPET: Concept, Design, and Applications. Chem Rev 2020;120:3787-851. [PMID: 32202104 DOI: 10.1021/acs.chemrev.9b00738] [Cited by in Crossref: 140] [Cited by in F6Publishing: 152] [Article Influence: 70.0] [Reference Citation Analysis]
15 Venepalli NK, Emmadi R, Danciu OC, Chowdhery R, Cabay RJ, Gaitonde S, Aardsma N, Kothari R, Liu LC, Fischer JH, Zaidi A, Russell MJ, Dudek AZ. Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R. American Journal of Clinical Oncology 2019;42:862-9. [DOI: 10.1097/coc.0000000000000611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Wei W, Ni D, Ehlerding EB, Luo QY, Cai W. PET Imaging of Receptor Tyrosine Kinases in Cancer. Mol Cancer Ther 2018;17:1625-36. [PMID: 30068751 DOI: 10.1158/1535-7163.MCT-18-0087] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
17 Xi JJ, He RY, Zhang JK, Cai ZB, Zhuang RX, Zhao YM, Shao YD, Pan XW, Shi TT, Dong ZJ, Liu SR, Kong LM. Design, synthesis, and biological evaluation of novel 3-(thiophen-2-ylthio)pyridine derivatives as potential multitarget anticancer agents. Arch Pharm (Weinheim) 2019;352:e1900024. [PMID: 31338897 DOI: 10.1002/ardp.201900024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Zhang J, Xi J, He R, Zhuang R, Kong L, Fu L, Zhao Y, Zhang C, Zeng L, Lu J, Tao R, Liu Z, Zhu H, Liu S. Discovery of 3-(thiophen/thiazole-2-ylthio)pyridine derivatives as multitarget anticancer agents. Med Chem Res 2019;28:1633-47. [DOI: 10.1007/s00044-019-02400-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
19 Bosma SE, van Driel PB, Hogendoorn PC, Dijkstra PS, Sier CF. Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma. J Surg Oncol 2018;118:906-14. [PMID: 30212597 DOI: 10.1002/jso.25224] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]